Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Selective factor Xa inhibitors designed by Cor Therapeutics researchers

Nov. 8, 2000

New protein from leeches with utility in thromboembolic diseases

Oct. 27, 2000

C&C describes new series of thrombin inhibitors

Oct. 25, 2000

U.S. launch of Innohep as DVT therapy announced at San Francisco meeting

Oct. 24, 2000

Pharmacokinetics, pharmacodynamics and safety of i.v. RGD-891 studied in healthy volunteers

Oct. 24, 2000

Novel compounds identified at Merck as factor Xa inhibitors

Oct. 19, 2000

International patent coverage obtained for new thrombin inhibitors from Boehringer Ingelheim

Oct. 10, 2000

IND filed by Endovasc for Liprostin

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

New factor Xa inhibitors with therapeutic and diagnostic uses

Sep. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...